Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized to achieve best-in-class pharmacology against highly validated disease targets.
We are dedicated to the discovery and development of best-in-class therapeutics that can improve the lives of people living with cancer. Leveraging deep expertise in cancer biology and a world class medicinal chemistry team, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer care through patient-focused precision medicine.
Company Details
- Employees
- 48
- Founded
- 2021
- Address
- 200 Powder Mill Road, Wilmington,de 19803,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.synnovationtx.com
- Keywords
- Medicinal Chemistry, Cellular Assays, In Vivo Pharmocology, Process Chemistry, Drug Discovery, Biochemical Assays.
- HQ
- Wilmington, DE
Synnovation Therapeutics Questions
Synnovation Therapeutics's website is http://www.synnovationtx.com
Synnovation Therapeutics's LinkedIn profile is https://www.linkedin.com/company/synnovationtx
Synnovation Therapeutics has
48 employees.
View email and phone details for 48
employees at Synnovation Therapeutics.
Synnovation Therapeutics's industry is
Pharmaceutical Manufacturing
Synnovation Therapeutics's top competitors are
Affinity Research Chemicals, Inc,
Nikang Therapeutics Inc.,
Prelude Therapeutics,
Cour Pharma,
Incyte,
Scorpion Therapeutics,
Quanta Therapeutics,
Accent Therapeutics, Inc.,
Claris Bio,
Calluna Pharma.
Synnovation Therapeutics's categories are Pharmaceutical Manufacturing
Synnovation Therapeutics's founding year is 2021
